Overview
Updated 14 Jul 2026
Gary Gilkeson, MD, is Distinguished University Professor of Medicine/Microbiology and Immunology at Medical University of South Carolina (MUSC). The public record shows 361 publications with 24,026 citations (h-index 83), centered on Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 6 companies, 14 NIH-funded awards (1996–2026).
- Most recent indexed publication: 2025 · Lupus science & medicine
- Top research focus: Systemic Lupus Erythematosus Research
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 255.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- Chair Emeritus
Medical-Scientific Advisory Council, Lupus Foundation of America
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupus.org ↗ - Member
National Board of Directors, Lupus Foundation of America
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupusnewstoday.com ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
Sponsor: Medical University of South Carolina
InvestigatorPhase 2CompletedNCT02633163
Industry payments
Updated 14 Jul 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- UCB, Inc.Program year20251 payment
- PFIZER INC.Program year20241 payment
NIH funding
Updated 14 Jul 2026
14 NIH research awards on record, funded 1996–2026 per NIH RePORTER. The latest:
- A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)
Medical University of South Carolina
FY2026$1,278,903U01AI184159 - A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)
Medical University of South Carolina
FY2025$1,459,720U01AI184159 - Training Grant in Inflammatory and Fibrosing Diseases
Medical University of South Carolina
FY2025$242,371T32AR050958
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far.
Arthritis & rheumatology (Hoboken, N.J.)
2022
Most-cited worksby citation count (OpenAlex)
- 01Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis1,128 citations2005
- 02
- 03
- 04
- 05Vitamin D deficiency in systemic lupus erythematosus442 citations2005
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
2060 Sam Rittenberg Boulevard, 2nd Floor, West Ashley, SC 29407
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
- BS
Baylor University (summa cum laude)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗ - MD
University of Texas Southwestern Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗ - Internal medicine residency
University of North Carolina at Chapel Hill
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lupusnewstoday.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →education.musc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →education.musc.edu ↗
Media & interviewspress, podcasts and appearances
- Podcast: "Mesenchymal stromal cells: a potential new SLE treatment option?"
Lupus Science and Medicine Podcast (interview on phase I MSC trial for refractory lupus)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →music.amazon.com ↗ - Podcast: "Gary Gilkeson, MD, on Lupus and Lupus Nephritis Among Black Patients"
Rheumatology & Arthritis Learning Network / Consultant360 (discusses SLE and lupus nephritis prevalence among African Americans …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →soundcloud.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/gary-gilkeson-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/gary-gilkeson-81b360115
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Gary-Gilkeson
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
consultant360.com/podcast/consultant360/lupus-nephritis/gary-gilkeson-md-lupus-and-lupus-nephritis-among-black
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com ↗ - Other
lupus.org/leadership/gary-s-gilkeson-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Spotify
music.amazon.com/es-co/podcasts/e00baa91-2d65-4ac4-8406-f9a7a4419313/episodes/df34f6fd-f8a6-4b81-a4f3-f5ec90496f03/lupus-science-and-medicine-podcast-mesenchymal-stromal-cells-a-potential-new-sle-treatment-option
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →music.amazon.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Zile, MD
Medical University of South Carolina
- 857
- publications
- 123
- h-index
- 7
- trials
Diane Kamen, MD
Medical University of South Carolina
- 337
- publications
- 70
- h-index
- 6
- trials
Patrick Flume, MD
Medical University of South Carolina
- 403
- publications
- 58
- h-index
- 13
- trials